1. Home
  2. RNXT vs JZ Comparison

RNXT vs JZ Comparison

Compare RNXT & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • JZ
  • Stock Information
  • Founded
  • RNXT 2012
  • JZ 2011
  • Country
  • RNXT United States
  • JZ China
  • Employees
  • RNXT N/A
  • JZ N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • JZ Other Consumer Services
  • Sector
  • RNXT Health Care
  • JZ Real Estate
  • Exchange
  • RNXT Nasdaq
  • JZ Nasdaq
  • Market Cap
  • RNXT 31.6M
  • JZ 26.7M
  • IPO Year
  • RNXT 2021
  • JZ 2022
  • Fundamental
  • Price
  • RNXT $1.03
  • JZ $0.94
  • Analyst Decision
  • RNXT Strong Buy
  • JZ
  • Analyst Count
  • RNXT 1
  • JZ 0
  • Target Price
  • RNXT $9.00
  • JZ N/A
  • AVG Volume (30 Days)
  • RNXT 214.8K
  • JZ 8.9K
  • Earning Date
  • RNXT 03-31-2025
  • JZ 09-27-2024
  • Dividend Yield
  • RNXT N/A
  • JZ N/A
  • EPS Growth
  • RNXT N/A
  • JZ N/A
  • EPS
  • RNXT N/A
  • JZ N/A
  • Revenue
  • RNXT N/A
  • JZ $50,810,288.00
  • Revenue This Year
  • RNXT N/A
  • JZ N/A
  • Revenue Next Year
  • RNXT N/A
  • JZ N/A
  • P/E Ratio
  • RNXT N/A
  • JZ N/A
  • Revenue Growth
  • RNXT N/A
  • JZ N/A
  • 52 Week Low
  • RNXT $0.77
  • JZ $0.53
  • 52 Week High
  • RNXT $1.86
  • JZ $2.37
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 35.37
  • JZ 55.46
  • Support Level
  • RNXT $1.00
  • JZ $0.83
  • Resistance Level
  • RNXT $1.18
  • JZ $0.95
  • Average True Range (ATR)
  • RNXT 0.10
  • JZ 0.07
  • MACD
  • RNXT -0.03
  • JZ 0.01
  • Stochastic Oscillator
  • RNXT 6.00
  • JZ 78.69

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: